Mark Paxton
Advisor and Investor
Mark is a seasoned FDA regulatory attorney and former regulatory counsel within the Office of Compliance at the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER). With more than two decades of experience spanning government, industry, and private practice, he has advised global pharmaceutical companies, trade associations, and emerging innovators on complex regulatory, compliance, and international market issues. Based in Kentucky, Mark is the founder of White Oak AI Law, where he focuses on the intersection of life sciences and artificial intelligence. As both an advisor and investor in our company, he brings unparalleled insight into FDA regulatory pathways, compliance strategy, and the evolving landscape of biopharma innovation.
FDA Regulatory
Legal Counsel